Does ALEMTUZUMAB Cause Hypothyroidism? 227 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 227 reports of Hypothyroidism have been filed in association with ALEMTUZUMAB (Campath). This represents 1.6% of all adverse event reports for ALEMTUZUMAB.
227
Reports of Hypothyroidism with ALEMTUZUMAB
1.6%
of all ALEMTUZUMAB reports
5
Deaths
105
Hospitalizations
How Dangerous Is Hypothyroidism From ALEMTUZUMAB?
Of the 227 reports, 5 (2.2%) resulted in death, 105 (46.3%) required hospitalization, and 15 (6.6%) were considered life-threatening.
Is Hypothyroidism Listed in the Official Label?
Yes, Hypothyroidism is listed as a known adverse reaction in the official FDA drug label for ALEMTUZUMAB.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Hypothyroidism?
PEMBROLIZUMAB (2,326)
LEVOTHYROXINE (2,107)
NIVOLUMAB (1,939)
LENVATINIB (1,375)
ATEZOLIZUMAB (881)
ALBUTEROL (877)
CARBOPLATIN (830)
IPILIMUMAB (770)
AMIODARONE (764)
PREDNISONE (739)
Which ALEMTUZUMAB Alternatives Have Lower Hypothyroidism Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET